Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	XAGRID Only	804
Overall Study	STARTED	XAGRID+Other (Cytoreductives)	141
Overall Study	STARTED	Other (Cytoreductives)	2,666
Overall Study	STARTED	No Essential Thrombocythemia (ET) Therapy	110
Overall Study	Initiated Treatment	XAGRID Only	804
Overall Study	Initiated Treatment	XAGRID+Other (Cytoreductives)	141
Overall Study	Initiated Treatment	Other (Cytoreductives)	2,666
Overall Study	Initiated Treatment	No Essential Thrombocythemia (ET) Therapy	38
Overall Study	COMPLETED	XAGRID Only	563
Overall Study	COMPLETED	XAGRID+Other (Cytoreductives)	108
Overall Study	COMPLETED	Other (Cytoreductives)	1,758
Overall Study	COMPLETED	No Essential Thrombocythemia (ET) Therapy	23
Overall Study	NOT COMPLETED	XAGRID Only	241
Overall Study	NOT COMPLETED	XAGRID+Other (Cytoreductives)	33
Overall Study	NOT COMPLETED	Other (Cytoreductives)	908
Overall Study	NOT COMPLETED	No Essential Thrombocythemia (ET) Therapy	87

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00567502/flow